Antigenic shift and increased incidence of meningococcal disease

Journal of Infectious Diseases

Volumn 193, Issue 9, 2006, Pages 1266-1274

  Harrison, Lee H ^a,b,d   Jolley, Keith A ^c   Shutt, Kathleen A ^b   Marsh, Jane W ^b   O'Leary, Mary ^b   Sanza, Laurie Thomson ^a   Maiden, Martin C J ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; OUTER MEMBRANE PROTEIN;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENIC SHIFT; ANTIGENIC VARIATION; ARTICLE; BACTERIAL GENE; ENDEMIC DISEASE; FETA GENE; GENE SEQUENCE; HEALTH SURVEY; HORIZONTAL GENE TRANSFER; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; POPULATION RESEARCH; PORA GENE; PORB GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; UNITED STATES;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; GENES, BACTERIAL; HUMANS; INCIDENCE; MENINGOCOCCAL INFECTIONS; MOLECULAR SEQUENCE DATA; MUTATION; NEISSERIA MENINGITIDIS; PORINS;

EID: 33646043196     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/501371     Document Type: Article

References (47)

1. Moore PS. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis 1992; 14:515-25.
2. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337:970-6.
3. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001; 344:1378-88.
4. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA 1995; 273:383-9.
5. Zangwill KM, Schuchat A, Riedo FX, et al. School-based clusters of meningococcal disease in the United States: descriptive epidemiology and a case-control analysis. JAMA 1997; 277:389-95.
6. Finn R, Groves C, Coe M, Pass M, Harrison LH. Cluster of serogroup C meningococcal disease associated with attendance at a party. South Med J 2001; 94:1192-4.
7. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:1-21.
8. Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR CDC Surveill Summ 1993; 42:21-30.
9. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999; 180:1894-901.
10. McEllistrem MC, Kolano JA, Pass MA, et al. Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg Infect Dis 2004; 10:451-6.
11. Maiden MC, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95:3140-5.
12. Feavers IM, Fox AJ, Gray S, Jones DM, Maiden MC. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immunol 1996; 3:444-50.
13. Thompson EA, Feavers IM, Maiden MC. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 2003; 149:1849-58.
14. Luijkx TA, van Dijken H, Hamstra HJ, et al. Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form. Infect Immun 2003; 71:6367-71.
15. Urwin R, Kaczmarski EB, Guiver M, Fox AJ, Maiden MC. Amplification of the meningococcal porB gene for non-culture serotype characterization. Epidemiol Infect 1998; 120:257-62.
16. Wright JC, Williams JN, Christodoulides M, Heckels JE. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis. Infect Immun 2002; 70:4028-34.
17. Pettersson A, Kuipers B, Pelzer M, et al. Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific. Infect Immun 1990; 58:3036-41.
18. Schuchat A, Hilger T, Zell E, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001; 7:92-9.
19. Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students. JAMA 1999; 281:1906-10.
20. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA 2001; 286:694-9.
21. Wedege E, Hoiby EA, Rosenqvist E, Froholm LO. Serotyping and sub-typing of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J Med Microbiol 1990; 31:195-201.
22. Holmes EC, Urwin R, Maiden MC. The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis. Mol Biol Evol 1999; 16:741-9.
23. Urwin R, Feavers IM, Jones DM, Maiden MC, Fox AJ. Molecular variation of meningococcal serotype 4 antigen genes. Epidemiol Infect 1998; 121:95-101.
24. Russell JE, Jolley KA, Feavers IM, Maiden MCJ, Suker J. PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 2004; 10:674-8.
25. Feavers IM, Gray SJ, Urwin R, et al. Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak. J Clin Microbiol 1999; 37:3883-7.
26. Tettelin H, Saunders NJ, Heidelberg J, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 2000; 287:1809-15.
27. Staden R. The Staden sequence analysis package. Mol Biotechnol 1996; 5:233-41.
28. Jolley KA, Chan MS, Maiden MC. mlstdbNet- distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 2004; 5:86.
29. Russell JE, Jolley KA, Feavers IM, Maiden MC, Suker J. PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 2004; 10:674-8.
30. Feil EJ, Enright MC, Spratt BG. Estimating the relative contributions of mutation and recombination to clonal diversification: a comparison between Neisseria meningitidis and Streptococcus pneumoniae. Res Microbiol 2000; 151:465-9.
31. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004; 186:1518-30.
32. McEllistrem MC, Kolano JA, Pass MA, et al. Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg Infect Dis 2004; 10:451-6.
33. Feil EJ, Maiden MC, Achtman M, Spratt BG. The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol Biol Evol 1999; 16:1496-502.
34. Swartley JS, Marfin AA, Edupuganti S, et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci USA 1997; 94:271-6.
35. Mayer LW, Reeves MW, Al-Hamdan N, et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis 2002; 185:1596-605.
36. McGuinness BT, Clarke IN, Lambden PR, et al. Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet 1991; 337:514-7.
37. Gupta S, Maiden MC, Feavers IM, Nee S, May RM, Anderson RM. The maintenance of strain structure in populations of recombining infectious agents. Nat Med 1996; 2:437-42.
38. Wang JF, Caugant DA, Morelli G, Koumare B, Achtman M. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis 1993; 167:1320-9.
39. van der Ende A, Hopman CT, Dankert J. Deletion of porA by recombination between clusters of repetitive extragenic palindromic sequences in Neisseria meningitidis. Infect Immun 1999; 67:2928-34.
40. van der Ende A, Hopman CT, Keijzers WC, et al. Outbreak of meningococcal disease caused by PorA-deficient meningococci. J Infect Dis 2003; 187:869-71.
41. Wyle FA, Artenstein MS, Brandt BL, et al. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 1972; 126:514-21.
42. Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet 1983; 2:355-7.
43. Finne J, Bitter-Suermann D, Goridis C, Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 1987; 138:4402-7.
44. Granoff DM, Feavers IM, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. New York: Saunders, 2004: 959-87.
45. Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287:1816-20.
46. Danzig L. Meningococcal vaccines. Pediatr Infect Dis J 2004; 23:S285-92.
47. Sacchi CT, Whitney AM, Popovic T, et al. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 2000; 182:1169-76.